• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非胃肠病学家进行结肠镜筛查时的疗效丧失和成本效益。

Loss of efficacy and cost-effectiveness when screening colonoscopy is performed by nongastroenterologists.

机构信息

Division of Gastroenterology, Nuovo Regina Margherita Hospital, Rome, Italy.

出版信息

Cancer. 2012 Sep 15;118(18):4404-11. doi: 10.1002/cncr.27664. Epub 2012 Jun 15.

DOI:10.1002/cncr.27664
PMID:22707430
Abstract

BACKGROUND

Specialty of the endoscopist has been related to the postcolonoscopy interval risk of colorectal cancer (CRC). However, the impact of such a difference on the long-term CRC prevention rate by screening colonoscopy is largely unknown.

METHODS

A Markov model was constructed to simulate the efficacy and cost of colonoscopy screening according to the specialty of the endoscopist in 100,000 individuals aged 50 years until death. The postcolonoscopy interval CRC risk (0.02%) and the relative risk (1.4) of interval CRC between gastroenterologist (GI) endoscopists and non-GI endoscopists were extracted from the literature. Both efficacy and costs were projected over a steady-state US population. Eventual increase in endoscopic capacity when assuming all procedures to be performed by GI endoscopists was simulated.

RESULTS

According to the simulation model, screening colonoscopy performed by non-GI endoscopists resulted in a 11% relative reduction in the long-term CRC incidence prevention rate compared with the same procedure performed by GI endoscopists. When projected on the US population, the reduced non-GI efficacy resulted in an additional 3043 CRC cases and the loss of $200 million per year. When increasing the relative risk from 1.4 to 2.0, the difference in the prevention rate between GI endoscopists and non-GI endoscopists increased to 19%. It increased further to 38% when also assuming a 3-fold increase in the risk of interval CRC. An additional 165 screening colonoscopies per endoscopist per year would be required to shift all non-GI procedures to GI endoscopists.

CONCLUSIONS

When screening colonoscopy is performed by non-GI endoscopists, a substantial reduction in the long-term CRC prevention rate may be expected. Such difference appeared to be greater when a suboptimal efficacy of colonoscopy in preventing CRC was assumed. A 10-year saving of $2 billion may be expected when shifting all screening colonoscopies from non-GI endoscopists to GI endoscopists.

摘要

背景

内镜医师的专业特长与结肠镜检查后的结直肠癌(CRC)风险间隔有关。然而,这种差异对筛查结肠镜检查的长期 CRC 预防率的影响在很大程度上是未知的。

方法

根据内镜医师的专业特长,采用马尔可夫模型对 10 万名 50 岁个体直至死亡的结肠镜筛查效果和成本进行模拟。从文献中提取内镜医师为胃肠病学家(GI)和非胃肠病学家时,结肠镜检查后 CRC 风险(0.02%)和 CRC 间隔的相对风险(1.4)。在稳定的美国人群中预测疗效和成本。假设所有操作均由 GI 内镜医师进行,模拟内镜能力的最终增加。

结果

根据模拟模型,与 GI 内镜医师进行相同的结肠镜筛查相比,非 GI 内镜医师进行的筛查结肠镜检查导致长期 CRC 发病率预防率降低 11%。当预测到美国人群时,非 GI 效果降低导致每年额外增加 3043 例 CRC 病例和损失 2 亿美元。当将相对风险从 1.4 增加到 2.0 时,GI 内镜医师和非 GI 内镜医师之间的预防率差异增加到 19%。当假设 CRC 间隔风险增加 3 倍时,差异进一步增加到 38%。每年每内镜医师增加 165 次筛查性结肠镜检查,将所有非 GI 操作转移到 GI 内镜医师手中。

结论

当非 GI 内镜医师进行筛查结肠镜检查时,预计长期 CRC 预防率会大幅降低。当假设结肠镜检查预防 CRC 的效果不理想时,这种差异似乎更大。当将所有筛查结肠镜检查从非 GI 内镜医师转移到 GI 内镜医师时,预计可节省 20 亿美元的 10 年成本。

相似文献

1
Loss of efficacy and cost-effectiveness when screening colonoscopy is performed by nongastroenterologists.非胃肠病学家进行结肠镜筛查时的疗效丧失和成本效益。
Cancer. 2012 Sep 15;118(18):4404-11. doi: 10.1002/cncr.27664. Epub 2012 Jun 15.
2
Endoscopist-directed propofol administration versus anesthesiologist assistance for colorectal cancer screening: a cost-effectiveness analysis.内镜医师指导下的丙泊酚给药与麻醉医师协助用于结直肠癌筛查:成本效益分析。
Endoscopy. 2012 May;44(5):456-64. doi: 10.1055/s-0032-1308936. Epub 2012 Apr 24.
3
Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy: a cost-effectiveness analysis.低剂量阿司匹林联合内镜用于结直肠癌的一级预防:成本效益分析。
Gut. 2012 Aug;61(8):1172-9. doi: 10.1136/gutjnl-2011-300206. Epub 2011 Oct 13.
4
Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand.结直肠癌筛查对临床和经济结果以及卫生服务需求的全国性预期影响。
Gastroenterology. 2005 Oct;129(4):1151-62. doi: 10.1053/j.gastro.2005.07.059.
5
Cost effectiveness and projected national impact of colorectal cancer screening in France.法国结直肠癌筛查的成本效益和预期的全国影响。
Endoscopy. 2011 Sep;43(9):780-93. doi: 10.1055/s-0030-1256409. Epub 2011 May 27.
6
Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.亚洲结直肠肿瘤筛查及结直肠癌管理的成本效益分析
Aliment Pharmacol Ther. 2008 Aug 1;28(3):353-63. doi: 10.1111/j.1365-2036.2008.03726.x.
7
Efficacy and cost-effectiveness of screening colonoscopy according to the adenoma detection rate.根据腺瘤检出率评估筛查结肠镜检查的疗效和成本效益。
United European Gastroenterol J. 2015 Apr;3(2):200-7. doi: 10.1177/2050640614565199.
8
Screening based on risk for colorectal cancer is the most cost-effective approach.基于结直肠癌风险的筛查是最具成本效益的方法。
Clin Gastroenterol Hepatol. 2012 Mar;10(3):266-71.e1-6. doi: 10.1016/j.cgh.2011.11.011. Epub 2011 Nov 16.
9
Can colonoscopy remain cost-effective for colorectal cancer screening? The impact of practice patterns and the Will Rogers phenomenon on costs.结肠镜检查在结直肠癌筛查中仍然具有成本效益吗?实践模式和威尔·罗杰斯现象对成本的影响。
Am J Gastroenterol. 2013 Mar;108(3):296-301. doi: 10.1038/ajg.2012.195. Epub 2012 Dec 4.
10
Cost-effectiveness of capsule endoscopy in screening for colorectal cancer.胶囊内镜在结直肠癌筛查中的成本效益
Endoscopy. 2008 May;40(5):414-21. doi: 10.1055/s-2007-995565. Epub 2008 Feb 27.

引用本文的文献

1
Association between Endoscopist Volume and Interval Cancers after Colonoscopy: Results from the National Colorectal Cancer Screening Program in Korea.内镜医师工作量与结肠镜检查后间期癌症的关系:来自韩国国家结直肠癌筛查计划的结果。
Cancer Res Treat. 2024 Oct;56(4):1164-1170. doi: 10.4143/crt.2024.009. Epub 2024 Apr 16.
2
Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer.结直肠癌筛查:美国多学会专家组对医生和患者的建议。
Am J Gastroenterol. 2017 Jul;112(7):1016-1030. doi: 10.1038/ajg.2017.174. Epub 2017 Jun 6.
3
Colonoscopy in Colorectal Cancer Screening: Current Aspects.
结肠镜检查在结直肠癌筛查中的现状
Indian J Surg Oncol. 2015 Sep;6(3):237-50. doi: 10.1007/s13193-015-0410-3. Epub 2015 Apr 12.
4
Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program.粪便血红蛋白浓度影响因结肠镜检查质量不足导致的间期癌风险预测:台湾全国性结直肠癌筛查项目分析
Gut. 2017 Feb;66(2):293-300. doi: 10.1136/gutjnl-2015-310256. Epub 2015 Oct 29.
5
The impact of preventive screening resource distribution on geographic and population-based disparities in colorectal cancer in Mississippi.预防性筛查资源分配对密西西比州结直肠癌的地理和人群差异的影响。
BMC Res Notes. 2015 Sep 8;8:423. doi: 10.1186/s13104-015-1352-0.
6
Efficacy and cost-effectiveness of screening colonoscopy according to the adenoma detection rate.根据腺瘤检出率评估筛查结肠镜检查的疗效和成本效益。
United European Gastroenterol J. 2015 Apr;3(2):200-7. doi: 10.1177/2050640614565199.
7
Leadership training to improve adenoma detection rate in screening colonoscopy: a randomised trial.领导力培训以提高结肠镜筛查中腺瘤检出率:一项随机试验。
Gut. 2016 Apr;65(4):616-24. doi: 10.1136/gutjnl-2014-307503. Epub 2015 Feb 10.
8
Detection rates of premalignant polyps during screening colonoscopy: time to revise quality standards?筛查结肠镜检查期间癌前息肉的检出率:是时候修订质量标准了吗?
Gastrointest Endosc. 2015 Mar;81(3):567-74. doi: 10.1016/j.gie.2014.07.030. Epub 2015 Jan 10.
9
Colonoscopy: the current king of the hill in the USA.结肠镜检查:在美国当前处于领先地位。
Dig Dis Sci. 2015 Mar;60(3):639-46. doi: 10.1007/s10620-014-3448-0. Epub 2014 Dec 16.